Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime–Avibactam Combination: A Model-Informed Strategy for its Clinical Development Sherwin K. B. SyLuning ZhuangHartmut Derendorf Review Article 11 August 2018 Pages: 545 - 564
Cardiovascular Risk Management and Hepatitis C: Combining Drugs Elise J. SmoldersPeter J. G. ter HorstDavid M. Burger Review Article Open access 27 September 2018 Pages: 565 - 592
Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation Camille TronFlorian LemaitreEric Bellissant Review Article 10 November 2018 Pages: 593 - 613
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients Diansong ZhouJianguo LiHongmei Xu Original Research Article 24 October 2018 Pages: 615 - 625
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation Jurgen B. LangenhorstThomas P. C. DorloAlwin D. R. Huitema Original Research Article Open access 17 October 2018 Pages: 627 - 637
Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus Hanne HaahrThomas R. PieberTim Heise Original Research Article Open access 07 November 2018 Pages: 639 - 649
Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients Sander BinsAlwin D. R. HuitemaStijn L. W. Koolen Original Research Article Open access 27 October 2018 Pages: 651 - 658
Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies Helena EdlundSun Ku LeeNidal Al-Huniti Original Research Article 17 December 2018 Pages: 659 - 672
Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials Yulan QiKathleen McKeeverJack Shi Original Research Article Open access 23 November 2018 Pages: 673 - 683
Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials Yulan QiKathleen McKeeverJack Shi Correction 04 December 2018 Pages: 685 - 685